Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariadna Forray

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of General Internal Medicine|August 31, 2019
Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled TrialSteve Martino, Paula Zimbrean, Ariadna Forray, et al.
Academic Pediatrics|March 23, 2026
Clinicians' Perspectives on Implementing Contingency Management to Promote Parental Smoking Cessation in Routine Infant CareJulie D Flom, Deepa R Camenga, Veronika Shabanova, et al.
Plos One|July 25, 2020
Utilization, financial outcomes and stakeholder perspectives of a re-organized adult sickle cell programRobert Rousseau, Daniel F Weisberg, Jack Gorero, et al.
Epidemiology (Cambridge, Mass.)|September 9, 2011
Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?Kimberly A Yonkers, Nathan Gotman, Megan V Smith, et al.
Plos One|January 13, 2022
Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinicsAriadna Forray, Amanda Mele, Nancy Byatt, et al.
Journal of Women'S Health (2002)|May 21, 2024
Reporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on CareJoy S Kaufman, Kimberly A Yonkers, Caro Maltz, et al.
Frontiers in Genetics|January 24, 2024
Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizonsUppala Radhakrishna, Senthilkumar Sadhasivam, Rupa Radhakrishnan, et al.
Addictive Behaviors|September 8, 2023
Effectiveness of smoking cessation interventions among pregnant women: An updated systematic review and meta-analysisA Vila-Farinas, M Pérez-Rios, A Montes-Martinez, et al.
Journal of Occupational and Environmental Medicine|August 12, 2022
COVID-19 Traumatic Disaster Appraisal and Stress Symptoms Among Health Care Workers: Insights From the Yale Stress Self-assessmentKristine D Olson, Nia Fogelman, Laura Maturo, et al.
Frontiers in Genetics|July 12, 2023
Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndromeUppala Radhakrishna, Swapan K Nath, Lavanya V Uppala, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of General Internal Medicine|August 31, 2019
Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled TrialSteve Martino, Paula Zimbrean, Ariadna Forray, et al.
Academic Pediatrics|March 23, 2026
Clinicians' Perspectives on Implementing Contingency Management to Promote Parental Smoking Cessation in Routine Infant CareJulie D Flom, Deepa R Camenga, Veronika Shabanova, et al.
Plos One|July 25, 2020
Utilization, financial outcomes and stakeholder perspectives of a re-organized adult sickle cell programRobert Rousseau, Daniel F Weisberg, Jack Gorero, et al.
Epidemiology (Cambridge, Mass.)|September 9, 2011
Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?Kimberly A Yonkers, Nathan Gotman, Megan V Smith, et al.
Plos One|January 13, 2022
Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinicsAriadna Forray, Amanda Mele, Nancy Byatt, et al.
Journal of Women'S Health (2002)|May 21, 2024
Reporting Perinatal Substance Use to Child Protective Services: Obstetric Provider Perspectives on the Impact on CareJoy S Kaufman, Kimberly A Yonkers, Caro Maltz, et al.
Frontiers in Genetics|January 24, 2024
Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizonsUppala Radhakrishna, Senthilkumar Sadhasivam, Rupa Radhakrishnan, et al.
Addictive Behaviors|September 8, 2023
Effectiveness of smoking cessation interventions among pregnant women: An updated systematic review and meta-analysisA Vila-Farinas, M Pérez-Rios, A Montes-Martinez, et al.
Journal of Occupational and Environmental Medicine|August 12, 2022
COVID-19 Traumatic Disaster Appraisal and Stress Symptoms Among Health Care Workers: Insights From the Yale Stress Self-assessmentKristine D Olson, Nia Fogelman, Laura Maturo, et al.
Frontiers in Genetics|July 12, 2023
Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndromeUppala Radhakrishna, Swapan K Nath, Lavanya V Uppala, et al.
Pageof 6